Pura Vida Investments’s Repligen RGEN Stock Holding History

Pura Vida Investments’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,100	Closed	-$4.73M	–	91
2023 Q1	$4.73M	Buy	+28,100	New	+$5.01M	0.48%	49

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Pura Vida Investments's RGEN Position: Q2 2024 in Review

Pura Vida Investments sold out of Repligen (RGEN) in Q2 2024, closing a stake of 11,225 shares — an estimated $2.06M sold.

Pura Vida Investments first reported a position in RGEN in Q4 2020 and held it in 4 quarters. The position peaked at $4.79M in Q4 2020. 454 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

Pura Vida Investments reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
Pura Vida Investments sold 11,225 Repligen shares in Q2 2024, an estimated $2.06M.
Pura Vida Investments first reported a position in Repligen in Q4 2020 and held it in 4 quarters.
Pura Vida Investments's Repligen position peaked at $4.79M in Q4 2020.
454 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.